Shionogi & Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Shionogi & Co. (Shionogi or 'the group') is engaged in the research, development, manufacture, and marketing of ethical drugs, over-the-counter drugs and diagnostic products. Shionogi operates in Japan, Europe, North America and other regions of the world. It is headquartered in Osaka, Japan, and employed 6,059 people as on March 31, 2015.
Detailed information on Shionogi & Co., Ltd. required for business and competitor intelligence needs
A study of the major internal and external factors affecting Shionogi & Co., Ltd. in the form of a SWOT analysis
An in-depth view of the business model of Shionogi & Co., Ltd. including a breakdown and examination of key business segments
Intelligence on Shionogi & Co., Ltd.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
News about Shionogi & Co., Ltd., such as business expansion, restructuring, and contract wins
Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to buy
Gain understanding of Shionogi & Co., Ltd. and the factors that influence its strategies.
Track strategic initiatives of the company and latest corporate news and actions.
Assess Shionogi & Co., Ltd. as a prospective partner, vendor or supplier.
Support sales activities by understanding your customers' businesses better.
Stay up to date on Shionogi & Co., Ltd.'s business structure, strategy and prospects.